Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays

被引:12
|
作者
Morris, Carol J. [1 ]
Hill, Mary [1 ]
de Medina, Maria [1 ]
Herman, Christine [2 ]
Cloherty, Gavin A. [2 ]
Martin, Paul [1 ]
机构
[1] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA
[2] Abbott Mol, Des Plaines, IL USA
关键词
HBV viral load; HBeAg negative; HBeAg positive; Abbott RealTime HBV assay; Cobas TaqMan HBV assay; B-VIRUS DNA; CHRONIC HEPATITIS-B; TIME PCR ASSAY; PERFORMANCE; LEVEL; RISK;
D O I
10.1016/j.jviromet.2013.06.036
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Monitoring the serum hepatitis B viral DNA levels with sensitive realtime PCR assays is strongly recommended for the management of patients with chronic HBV infection. This study compares the performance of two realtime HBV quantitative PCR assays with samples from chronic HBeAg(+) and HBeAg(-) patients. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:391 / 393
页数:3
相关论文
共 50 条
  • [21] Comparison of Abbott RealTime HIV-1 and Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Assays
    Abravaya, K.
    Hackett, J.
    Swanson, P.
    Huang, S.
    Tang, N.
    Robinson, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 587 - 587
  • [22] Performance of the Abbott RealTime and Roche Cobas TaqMan Hepatitis C Virus (HCV) Assays for Quantification of HCV Genotypes
    LaRue, Heidi
    Rigali, Lisa
    Balada-Llasat, Joan-Miquel
    Pancholi, Preeti
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (05) : 1769 - 1772
  • [23] Performance of the new cobas® HBV Assay on the cobas® 6800 system in comparison to different TaqMan® assays
    Maasoumy, Benjamin
    Luk, Kevin
    Bremer, Birgit
    Lehmann, Patrick
    Marins, Ed G.
    Michel-Treil, Veronique
    Gelman, Ekaterina
    Njoya, Merlin
    Canchola, Jesse A.
    Simon, Christian O.
    Wedemeyer, Heiner
    HEPATOLOGY, 2015, 62 : 989A - 989A
  • [24] HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Entecavir
    Sungur, Murvet
    Tuzcuoglu, Isil
    Acilar, Kemal
    Gokmen, Tulay
    Kurt, Kamile
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 649 - 649
  • [25] HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg-negative patients with chronic HBV infection
    Yang, Danli
    Zou, Jun
    Wang, Leijie
    Chen, Xiangmei
    Lu, Fengmin
    HEPATOLOGY, 2022, 76 (04) : E69 - E70
  • [26] Dynamic range and reproducibility of hepatitis B virus (HBV) DNA detection and quantification by Cobas Taqman HBV, a real-time semiautomated assay
    Lindh, M
    Hannoun, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 4251 - 4254
  • [27] HBsAg transcomplementation of defective HBV genomes in HBeAg negative chronic HBV infected patients
    Peiffer, K. -H.
    Kuhnhenn, L.
    Jiang, B.
    Vermehren, J.
    Knop, V.
    Zeuzem, S.
    Sarrazin, C.
    Hildt, E.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S775 - S775
  • [28] Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy
    Ogawa, Eiichi
    Furusyo, Norihiro
    Murata, Masayuki
    Shimizu, Motohiro
    Toyoda, Kazuhiro
    Hotta, Taeko
    Uchiumi, Takeshi
    Hayashi, Jun
    ANTIVIRAL THERAPY, 2017, 22 (01) : 61 - 70
  • [30] HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Tenofovir disoproxil
    Tuzcuoglu, Isil
    Sungur, Murvet
    Acilar, Kemal
    Kurt, Kamile
    Gokmen, Tulay
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 648 - 649